NCT02599155

Brief Summary

The investigator will evaluate the influence of colloid administration on postoperative acute kidney injury in pediatric patients undergoing cardiac surgery under cardiopulmonary bypass.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2015

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

November 3, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 6, 2015

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2016

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2016

Completed
Last Updated

June 26, 2017

Status Verified

June 1, 2017

Enrollment Period

3 months

First QC Date

November 3, 2015

Last Update Submit

June 22, 2017

Conditions

Keywords

crystalloidcolloidchildreninfantcardiac surgery

Outcome Measures

Primary Outcomes (1)

  • Acute Kidney Injury

    From the day of surgery to postoperative 7 days

Secondary Outcomes (4)

  • Blood loss

    From the day of surgery to postoperative 7 days

  • Transfusion amount

    From the day of surgery to postoperative 7 days

  • Mechanical ventilation time

    From the day of surgery to postoperative 7 days

  • Length of ICU stay

    From the day of surgery to postoperative 7 days

Study Arms (2)

Crystalloid group

PLACEBO COMPARATOR

Crystalloid group receive only crystalloid for intravenous volume expansion. The same transfusion protocol is applied in both groups.

Drug: Crystalloid

Colloid group

ACTIVE COMPARATOR

Colloid group receive colloid preferentially for intravenous volume expansion, until 30 ml/kg. The same transfusion protocol is applied in both groups.

Drug: Colloid

Interventions

normal saline administration for volume expansion in hypovolemic status

Also known as: normal saline
Crystalloid group

HES 130/0.4 administration for volume expansion in hypovolemic status

Also known as: HES 130/0.4
Colloid group

Eligibility Criteria

AgeUp to 7 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Children aged less than 7 years old
  • American Society of Anesthesiology (ASA) physical status 1-3

You may not qualify if:

  • Preoperative creatinine \> 1.5mg/dl
  • History of dialysis
  • Liver function abnormality
  • Diabetes Mellitus
  • History of allergic reaction
  • Coagulation abnormality

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul national university hospital

Seoul, South Korea

Location

Related Publications (1)

  • Oh HW, Lee JH, Kim HC, Kim EH, Song IK, Kim HS, Kim JT. The effect of 6% hydroxyethyl starch (130/0.4) on acute kidney injury in paediatric cardiac surgery: a prospective, randomised trial. Anaesthesia. 2018 Feb;73(2):205-215. doi: 10.1111/anae.14129. Epub 2017 Nov 17.

MeSH Terms

Conditions

Acute Kidney Injury

Interventions

Crystalloid SolutionsSaline SolutionColloidsHydroxyethyl Starch Derivatives

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Isotonic SolutionsSolutionsPharmaceutical PreparationsComplex MixturesDosage FormsStarchDietary CarbohydratesCarbohydratesGlucansPolysaccharides

Study Officials

  • Jin-Tae Kim, PhD

    Seoul National University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 3, 2015

First Posted

November 6, 2015

Study Start

November 1, 2015

Primary Completion

February 1, 2016

Study Completion

March 1, 2016

Last Updated

June 26, 2017

Record last verified: 2017-06

Data Sharing

IPD Sharing
Will not share

Locations